Gene · 6240
Papers3,003
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,003
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Systematic Review of Progress toward Unlocking the Power of Epigenetics in NSCLC: Latest Updates and Perspectives. | Cells | 2023 | 36980246 | PubTator, text mining | PubMed |
| Molecular Research in Pancreatic Cancer: Small Molecule Inhibitors, Their Mechanistic Pathways and Beyond. | Curr Issues Mol Biol | 2023 | 36975494 | PubTator, text mining | PubMed |
| A novel predictive model of microvascular invasion in hepatocellular carcinoma based on differential protein expression. | BMC Gastroenterol | 2023 | 36973651 | PubTator, text mining | PubMed |
| Reliability and accuracy of single-molecule FRET studies for characterization of structural dynamics and distances in proteins. | Nat Methods | 2023 | 36973549 | PubTator, text mining | PubMed |
| Nucleotide metabolism: a pan-cancer metabolic dependency. | Nat Rev Cancer | 2023 | 36973407 | PubTator, text mining | PubMed |
| An AKT1-and TRIM21-mediated phosphodegron controls proteasomal degradation of HuR enabling cell survival under heat shock. | iScience | 2023 | 36968077 | PubTator, text mining | PubMed |
| The oncogenic properties of the EWSR1::CREM fusion gene are associated with polyamine metabolism. | Sci Rep | 2023 | 36966162 | PubTator, text mining | PubMed |
| TDP-43 and other hnRNPs regulate cryptic exon inclusion of a key ALS/FTD risk gene, UNC13A. | PLoS Biol | 2023 | 36930682 | PubTator, text mining | PubMed |
| HuR modulation counteracts lipopolysaccharide response in murine macrophages. | Dis Model Mech | 2023 | 36912171 | PubTator, text mining | PubMed |
| A Brief Review on Chemoresistance; Targeting Cancer Stem Cells as an Alternative Approach. | Int J Mol Sci | 2023 | 36901917 | PubTator, text mining | PubMed |
| Isogenic Cell Lines Derived from Specific Organ Metastases Exhibit Divergent Cytogenomic Aberrations. | Cancers (Basel) | 2023 | 36900209 | PubTator, text mining | PubMed |
| Proteomics and metabolomics profiling reveal panels of circulating diagnostic biomarkers and molecular subtypes in stable COPD. | Respir Res | 2023 | 36899372 | PubTator, text mining | PubMed |
| Ribonucleotide reductase subunit switching in hepatoblastoma drug response and relapse. | Commun Biol | 2023 | 36882565 | PubTator, text mining | PubMed |
| Widespread allele-specific topological domains in the human genome are not confined to imprinted gene clusters. | Genome Biol | 2023 | 36869353 | PubTator, text mining | PubMed |
| Systems-level multi-omics characterization provides novel molecular insights into indomethacin toxicity. | Chem Biol Interact | 2023 | 36868495 | PubTator, text mining | PubMed |
| RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeling in pancreatic cancer. | Int J Oncol | 2023 | 36866763 | PubTator, text mining | PubMed |
| Oncogenic YAP mediates changes in chromatin accessibility and activity that drive cell cycle gene expression and cell migration. | Nucleic Acids Res | 2023 | 36864753 | PubTator, text mining | PubMed |
| Peptides that Mimic RS repeats modulate phase separation of SRSF1, revealing a reliance on combined stacking and electrostatic interactions. | Elife | 2023 | 36862748 | PubTator, text mining | PubMed |
| The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications. | Exp Mol Med | 2023 | 36854773 | PubTator, text mining | PubMed |
| Zika virus RNA structure controls its unique neurotropism by bipartite binding to Musashi-1. | Nat Commun | 2023 | 36854751 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6240/papers?page=16